NPR Highlights Ketamine’s Relief for Mending Broken Bridges in Brain NPR recently ran an article by John Hamilton titled, “Ketamine May Relieve Depression By Repairing Damaged Brain Circuits,” highlighting ketamine as a treatment option for depression as it repairs damaged brain circuits. This article is a great overview of where research currently stands with ketamine.…
A closer look at Spravato/Esketamine. This episode focuses on the definition of Treatment Resistant Depression and looks at whether patients must be prescribed to an antidepressant while using Spravato. Additionally, what does one do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc?
One thing that raised the eyebrows of everybody on the clinical team here at KWC relates to the recommended dosing of Spravato. On this episode, we discuss what the recommended dosing is during the stabilization and maintenance treatment phases. Is the dosing variable from patient to patient or fixed? What are the implications of utilizing a non-variable prescription for dosing?
This episode focuses on the cost of Spravato to the provide, end user, and insurer. What are the preliminary cost estimates for Spravato (wholesale)? Can we estimate the cost to the patient? Will insurance cover the drug? How will the treatment schedule effect the cost?
This episode focuses on how Spravato is administered. Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment?
On February 12, 2019 the FDA advisory committee recommended approval of Spravato (esketamine) for adults with treatment resistant depression. Hallelujah! The first new therapy in 30 years for patients suffering from this affliction, or is it?
A Ketamine Patient Story: 3 Months Later… I Feel Better In his most recent blog called Thought About Solutions, Matthew Hendricks, a 33-year-old technology enthusiast and patient at Ketamine Wellness Centers, shares his treatment results after 3 months of Ketamine infusion therapy. If you’ve been following Matthew’s journey you will know that after years of…
Bloomberg Business Highlights Ketamine’s Rise to Treat Suicide Ideation Bloomberg Businessweek recently ran an article by Cynthia Koons and Robert Langreth titled, “Ketamine Could Be the Key to Reversing America’s Suicide Rate”, highlighting Ketamine as a treatment option for treating suicidality and depression. This article is a great comprehensive analysis of Ketamine’s rise in the treatment of mental…
What is a superbill and will it help cover the cost of my ketamine infusion treatments? When patients call asking about insurance coverage, we will often reply: “Unfortunately, because it is an off label use, we are unable to partner proactively with insurance at this time. However, we can provide superbills and many patients have…
A Survey of the Thriving Ketamine Infusion Therapy Industry in Denver, Colorado If you’ve been to Colorado lately, you may have noticed it’s been doing some growing. The population is booming and transplants from all over are picking up and moving to this thriving state. Businesses are finding Denver to be a great home for…